SNF8 antibody (N-Term)
Quick Overview for SNF8 antibody (N-Term) (ABIN927326)
Target
See all SNF8 AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Binding Specificity
- N-Term
- 
                                            Cross-Reactivity
- Mouse (Murine), Rat (Rattus), Frog, Cow (Bovine), Dog (Canine), Chicken, Zebrafish (Brachydanio rerio)
- 
                                            Purification
- Purified
- 
                                            Immunogen
- EAP30 antibody was raised in rabbit using the N terminal of EAP30 as the immunogen
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- Optimal conditions should be determined by the investigator.
- 
                                            Comment
- 
                        EAP30 Blocking Peptide, (ABIN5613289), is also available for use as a blocking control in assays to test for specificity of this EAP30 antibody 
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Lyophilized
- 
                                            Concentration
- Lot specific
- 
                                            Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- 
                                            Handling Advice
- Avoid repeated freeze/thaw cycles.
- 
                                            Storage
- 4 °C/-20 °C
- 
                                            Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
 
- 
                                            
- 
    - SNF8 (Vacuolar-sorting Protein SNF8 (SNF8))
- 
                                            Alternative Name
- EAP30
- 
                                            Background
- ELL encodes an RNA polymerase II transcription factor that undergoes frequent translocation in acute myeloid leukemia. In addition to its elongation activity, ELL contains a novel type of RNA polymerase II interaction domain that is capable of repressing polymerase activity in promoter-specific transcription. EAP30 is a subunit of the ELL complex. EAP30 can interact with ELL and derepress ELL's inhibitory activity in vitro.SNF8, VPS25, and VPS36 form ESCRT-II, a complex involved in endocytosis of ubiquitinated membrane proteins. SNF8, VPS25, and VPS36 are also associated in a multiprotein complex with RNA polymerase II elongation factor. Synonyms: Polyclonal EAP30 antibody, Anti-EAP30 antibodyDot3 antibody, EAP30 antibody, VPS22 antibody.
 Target
- 
                    
 
                                     
                                     
                                    